IPO Listed

Generate Biomedicines IPO

US$400m raised

Lodged 26 Feb 2026 · NASDAQ: GENB · US$16.00 cash per share

Advisers

Generate Biomedicines

Issuer

Legal adviser
Issuer
Generate Biomedicines
Issuer based in
United States
Listed
2 Mar 2026
Sector
Biotech
Tags
Biotech, AI, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.